BMW

IBS and China weigh on FY24, FY25 automotive guidance disappoints but reflects tariffs

18/03/25 -"BMW’s FY24 results were mixed, impacted by underperformance in China, delivery halts due to the IBS issue, and a weak Q4. Revenue, EBIT, and EPS were below expectations, while FCF surpassed ..."

PDF page sample
Pages
60
Language
English
Published on
18/03/25
Download
You may also be interested by these reports :
09/05/25
Nokian reported soft Q1 results, with profitability significantly below expectations. The passenger car division was weighed down by higher raw ...
09/05/25
BMW’s Q1 results exceeded expectations in most metrics, except for revenue and FCF. Profitability was solid, with a resilient automotive margin ...
07/05/25
Ferrari reported strong Q1 results, with stable delivery numbers. Performance was bolstered by personalisation and a favourable product mix, ...
05/05/25
Mercedes reported a weaker-than-expected Q1 performance, mainly due to reduced contributions from the Vans and Mobility segments. Car profitability ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO